Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
- PMID: 31291952
- PMCID: PMC6617671
- DOI: 10.1186/s12931-019-1111-1
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
Abstract
Introduction: Airway eosinophilic inflammation is a characteristic of asthmatic patients and of a sub group of COPD subjects. Blood eosinophils are deemed as a good surrogate marker of sputum eosinophilic inflammation; however, controversial data have been published particularly in COPD. The aim of our study was to compare blood and sputum eosinophils in COPD and asthmatic patients in "real life".
Methods: Sputum was induced in stable patients with COPD or asthma with hypertonic saline solution and blood eosinophils were evaluated. Frequency of comorbidities was recorded. Correlations were performed stratifying patients by disease and comorbidities.
Results: 146 patients, 57 with COPD and 89 with asthma were evaluated. Blood and sputum eosinophils expressed as percentages were correlated in COPD (rho = 0.40; p = 0.004), but the entity of correlation was lower compared with asthmatic subjects (rho = 0.71; p < 0.0001). When blood eosinophils were expressed as counts the correlation was slightly lower than when expressed as percentages in COPD (rho = 0.35; p = 0.01) and in asthmatic patients (rho = 0.68; p < 0.0001). In COPD patients older than 73 years or with blood eosinophils higher than the median value (210.6 eos/μl), or co-diagnosed with hypertension, ischemic heart disease or atrial fibrillation no correlation between blood and sputum eosinophils was found. However, the effect of ischemic heart disease and atrial fibrillation could be driven by hypertension since most of these patients have this comorbidity.
Conclusion: Blood eosinophils correlated with sputum eosinophils to a lesser degree in COPD than in asthmatic patients. Older age, high blood eosinophils and hypertension affected the correlation between blood and sputum eosinophils, more studies are needed to evaluate the role of other cardiac comobidities.
Keywords: Airway inflammation; Asthma; COPD; Correlation; Eosinophils; Sputum.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.Curr Med Sci. 2019 Aug;39(4):560-567. doi: 10.1007/s11596-019-2074-7. Epub 2019 Jul 25. Curr Med Sci. 2019. PMID: 31346991
-
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.Int J Chron Obstruct Pulmon Dis. 2016 Jul 1;11:1495-504. doi: 10.2147/COPD.S100338. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27445469 Free PMC article.
-
Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.COPD. 2017 Apr;14(2):181-189. doi: 10.1080/15412555.2016.1260539. Epub 2016 Dec 16. COPD. 2017. PMID: 27983888
-
[Bronchoalveolar lavage and induced sputum in asthmatic and COPD patient].Pol Merkur Lekarski. 2003 Jun;14(84):545-7. Pol Merkur Lekarski. 2003. PMID: 14524267 Review. Polish.
-
The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.Curr Opin Pulm Med. 2015 Jan;21(1):74-9. doi: 10.1097/MCP.0000000000000118. Curr Opin Pulm Med. 2015. PMID: 25405671 Review.
Cited by
-
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects.Tuberc Respir Dis (Seoul). 2020 Jul;83(3):185-194. doi: 10.4046/trd.2020.0026. Epub 2020 Apr 29. Tuberc Respir Dis (Seoul). 2020. PMID: 32578413 Free PMC article.
-
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.Front Pharmacol. 2021 Nov 23;12:740803. doi: 10.3389/fphar.2021.740803. eCollection 2021. Front Pharmacol. 2021. PMID: 34887752 Free PMC article. Review.
-
Treatment Response Biomarkers in Asthma and COPD.Diagnostics (Basel). 2021 Sep 13;11(9):1668. doi: 10.3390/diagnostics11091668. Diagnostics (Basel). 2021. PMID: 34574009 Free PMC article. Review.
-
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5. Lancet. 2022. PMID: 36075255 Free PMC article. Review.
-
Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts.ERJ Open Res. 2020 Oct 5;6(4):00320-2020. doi: 10.1183/23120541.00320-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33043054 Free PMC article.
References
-
- Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP. Bleecker ER; National Heart, Lung, and Blood Institute severe asthma research program. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010;125:1028–1036. doi: 10.1016/j.jaci.2010.02.008. - DOI - PMC - PubMed
-
- Schleich FN, Chevremont A, Paulus V, Henket M, Manise M, Seidel L, Louis R. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. EurRespir J. 2014;44:7–108. - PubMed
-
- Turato G, Semenzato U, Bazzan E, Biondini D, Tinè M, Torrecilla N, Forner M, Marin JM, Cosio MG, Saetta M. Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease. Am J RespirCrit Care Med. 2018;197:1216–1219. doi: 10.1164/rccm.201708-1684LE. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical